An Overview of Omnitrope® for Adult Growth Hormone Deficiency in Italy
Reading Time: 3 minutes A recent examination has put a spotlight on the preliminary results for the safety and efficacy of Omnitrope®, a man-made growth hormone, for adults aged 30 and above with a deficiency in growth hormones. This "Italian Interim Snapshot" is part of a broader objective to understand the ongoing success and safety of Omnitrope® among Italian adults suffering from growth hormone deficiency (GHD) within the scope of the PATRO Adults study. The PATRO Adults Study: Innovative Research Towards the Treatment of GHD The PATRO Adults study is an international, long-term, observational, and non-invasive post-marketing research effort present in numerous European countries....





















